Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 2, 2023
Lithium impacts the function of hematopoietic stem cells via disturbing the endoplasmic reticulum stress and Hsp90 signalingYalin Liu, Yifan Zhao, Jiaojiao Wu, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 25, 2025
Lithium suppresses the Ras-Raf-MEK-ERK signaling in CD4 T cells and impairs the humoral immune systemJiaojiao Wu, Yifan Zhao, Jie Zhang, et al.Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraintsGuo-Hua Chu, Minghua Gu, Joel A Cassel, et al.Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonistsGuo-Hua Chu, Minghua Gu, Joel A Cassel, et al.The Open Medicinal Chemistry Journal|December 8, 2009
Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization InhibitorsGuo-Hua Chu, Bertrand Le Bourdonnec, Minghua Gu, et al.Bioorganic & Medicinal Chemistry Letters|February 20, 2007
Novel malonamide derivatives as potent kappa opioid receptor agonistsGuo-Hua Chu, Minghua Gu, Joel A Cassel, et al.Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Discovery of a series of aminopiperidines as novel iNOS inhibitorsBertrand Le Bourdonnec, Lara K Leister, Christopher A Ajello, et al.Nature Communications|December 8, 2015
Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacinPan F Chan, Velupillai Srikannathasan, Jianzhong Huang, et al.Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.Pageof 4